Abstract:Chao Tian, 1, &ast Yanyan Yang, 2, &ast Bing Li, 3 Meixin Liu, 4 Xiangqin He, 4 Liang Zhao, 4 Xiaoxia Song, 4 Tao Yu, 4, 5 Xian-Ming Chu 1, 6 1 Department of Cardiology, The Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China; 2 Department of Immunology, Basic Medicine School, Qingdao University, Qingdao, People's Republic of China; 3 Department of Genetics, Basic Medicine School, Qingdao University, Qingdao, People's Republic of China; 4 Department of Cardiac Ultrasound, The Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China; 5 Institute for Translational Medicine, The Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China; 6 Department of Cardiology, The Affiliated Cardiovascular Hospital of Qingdao University, Qingdao, People's Republic of China &astThese authors contributed equally to this work Correspondence: Tao Yu, Institute for Translational Medicine, The Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China, Tel/Fax +86-532-82991791, Email Xian-Ming Chu, Department of Cardiology, the Affiliated Hospital of Qingdao University, No. 59 Haier Road, Qingdao, 266100, People's Republic of China, Tel +86-532-82913257, Email Purpose: To explore the therapeutic mechanism of bone marrow mesenchymal stem cells derived exosomes (BMSC-Exos) for doxorubicin (DOX)-induced cardiotoxicity (DIC) and identify the long noncoding RNAs' (lncRNAs') anti-inflammation function derived by BMSC-Exos. Materials and Methods: High-throughput sequencing and transcriptome bioinformatics analysis of lncRNA were performed between DOX group and BEC (bone marrow mesenchymal stem cells derived exosomes coculture) group. Elevated lncRNA (ElncRNA) in the cardiomyocytes of BEC group compared with DOX group were confirmed. Based on the location and co-expression relationship between ElncRNA and its target genes, we predicted two target genes of ElncRNA, named cis_targets and trans_targets. The target genes were analyzed by enrichment analyses. Then, we identified the key cellular biological pathways regulating DIC. Experiments were performed to verify the therapeutic effects of exosomes and the origin of lncRNAs in vitro and in vivo. Results: Three hundred and one lncRNAs were differentially expressed between DOX and BEC groups (fold change > 1.5 and p < 0.05), of which 169 lncRNAs were elevated in the BEC group compared with the DOX group. GO enrichment analysis of target genes of ElncRNAs showed that they were predominantly involved in inflammation-associated processes. KEGG analysis indicated that their regulatory pathways were mainly involved in oxidative stress-induced inflammation and proliferation of cardiomyocyte. The verification experiments in vitro showed that the oxidative stress and cell deaths were decreased in BEC groups. Moreover, from the top 10 ElncRNAs identified in the sequencing results, MSTRG.98097.4 and MSTRG.58791.2 were both decreased in the DOX group and elevated in BEC group. While in verification experiments in vivo, only the expression of MSTRG.58791.2 is consistent with the result in vitro. Conclusion: Our results show that ElncRNA, MSTRG.58791.2, is possibly secreted by the BMSC-Exos and able to alleviate DIC by suppressing inflammatory response and inflammation-related cell death. Keywords: doxorubicin-induced cardiotoxicity, exosomes, inflammation, transcriptome sequencing analysis The rapid development of immune checkpoint inhibitors and targeted therapy has advanced tumor therapy into a new era of precision medicine. Chemotherapy remains the cornerstone of oncological treatment. Doxorubicin (DOX), a variety of cross-sectional anthracycline, is indispensable in chemotherapy. However, it can also induce senescence, 1 apoptosis, 2 pyroptosis, 3 autophagy, 4 and ferroptosis 5 of cardiomyocytes, causing arrhythmia, hypertrophic cardiomyopathy, and congestive heart failure while killing tumor cells. 6 The cardiovascular damage associated with DOX chemotherapy, termed doxorubicin-induced cardiotoxicity (DIC), seriously threatens the health of cancer patients due to its progressive, irreversible nature. 7 At present, dexrazoxane (DZR) is recognized as the only drug to prevent DIC, but it has a limited effect and poses the risk of secondary tumors or bone marrow suppression. 8 Therefore, there is a need to find potential biomarkers and elucidate the molecular mechanism of DIC, which will benefit the exploration of effective targets f -Abstract Truncated-

LncRNA GHET1 from bone mesenchymal stem cell–derived exosomes improves doxorubicin-induced pyroptosis of cardiomyocytes by mediating NLRP3

Doxorubicin induces cardiomyocyte pyroptosis via the TINCR-mediated posttranscriptional stabilization of NLR family pyrin domain containing 3.

Bone marrow stromal cell‐derived exosomes improve oxidative stress and pyroptosis in doxorubicin‐induced myocardial injury in vitro by regulating the transcription of GSDMD through the PI3K‐AKT‐Foxo1 pathway

PLCE1 enhances mitochondrial dysfunction to promote GSDME-mediated pyroptosis in doxorubicin-induced cardiotoxicity

Exosome Treatment Enhances Anti-Inflammatory M2 Macrophages and Reduces Inflammation-Induced Pyroptosis in Doxorubicin-Induced Cardiomyopathy

Inhibiting Mir-34A-5p Regulates Doxorubicin-Induced Autophagy Disorder and Alleviates Myocardial Pyroptosis by Targeting Sirt3-AMPK Pathway.

LncRNA ORLNC1 Promotes Bone Marrow Mesenchyml Stem Cell Pyroptosis Induced by Advanced Glycation End Production by Targeting miR-200b-3p/Foxo3 Pathway

Long-noncoding RNA MALAT1 sponges microRNA-92a-3p to inhibit doxorubicin-induced cardiac senescence by targeting ATG4a

Exosomal LncRNA–NEAT1 derived from MIF-treated mesenchymal stem cells protected against doxorubicin-induced cardiac senescence through sponging miR-221-3p

Mesenchymal Stem Cell-Derived Exosomes Ameliorate Doxorubicin-Induced Cardiotoxicity

Doxorubicin-Induced Cardiotoxicity May Be Alleviated by Bone Marrow Mesenchymal Stem Cell-Derived Exosomal lncRNA via Inhibiting Inflammation

Exogenous 8-hydroxydeoxyguanosine attenuates doxorubicin-induced cardiotoxicity by decreasing pyroptosis in H9c2 cardiomyocytes

Caspase‐3‐mediated GSDME induced Pyroptosis in breast cancer cells through the ROS/JNK signalling pathway

Involvement of ROS/NLRP3 Inflammasome Signaling Pathway in Doxorubicin-Induced Cardiotoxicity

Long Non-Coding RNA ENST00000508435 Promotes Breast Cancer Chemoresistance Through Pyroptosis Inhibition

Bardoxolone methyl attenuates doxorubicin-induced cardiotoxicity by inhibiting the TXNIP-NLRP3 pathway through Nrf2 activation

Long Noncoding RNA RMRP Ameliorates Doxorubicin-Induced Apoptosis by Interacting with PFN1 in a P53-Dependent Manner.

Bone marrow mesenchymal stem cell‐derived exosomes miR‐202‐5p inhibited pyroptosis to alleviate lung ischemic‐reperfusion injury by targeting CMPK2

Protective Effect of Long Noncoding RNA OXCT1-AS1 on Doxorubicin-Induced Apoptosis of Human Myocardial Cells by the Competitive Endogenous RNA Pattern

MicroRNA-194-5p Attenuates Doxorubicin-Induced Cardiomyocyte Apoptosis and Endoplasmic Reticulum Stress by Targeting P21-Activated Kinase 2

Exosomes derived from bone marrow mesenchymal stem cells regulate pyroptosis via the miR-143-3p/myeloid differentiation factor 88 axis to ameliorate intestinal ischemia-reperfusion injury